New Squamous Cell Carcinoma Study Results Reported from Copenhagen University Hospital Bispebjerg-Frederiksberg (Anti-pd-1 Immunotherapy With Adjuvant Ablative Fractional Laser Displays Increased Tumour Clearance of Squamous Cell Carcinoma, a...).

Předmět:	SQUAMOUS cell carcinoma UNIVERSITY hospitals IMMUNOTHERAPY TUMORS BLOOD proteins
Zdroj:	Immunotherapy Weekly; 2024, p1103-1103, 1p
Abstrakt:	A recent study conducted at Copenhagen University Hospital Bispebjerg-Frederiksberg in Denmark explored the effectiveness of combining anti-PD-1 immunotherapy with adjuvant ablative fractional laser (AFL) in treating squamous cell carcinoma (SCC). The study used a mouse model and found that the combination treatment resulted in the highest percentage of complete responders compared to untreated controls and monotherapies. Additionally, all three treatment interventions showed reduced tumor growth rates and increased survival times. The researchers concluded that the combination treatment may have an additive effect in treating SCC. This research has been peer-reviewed and published in Experimental Dermatology. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu